5 of 132 shown

Lobbying reported per quarter

reported amounts per quarter, latest version of each report

There are two charts here because there are two different amounts. A lobbying firm reports income: what it was paid. A company that lobbies for itself reports expenses: what it spent, under one of three accounting methods it picks itself. Both appear under this company, and they are not the same measurement — so they are never added, not in a bar and not in a total.

Reported income: what lobbying firms reported receiving from this company's clients, per quarter.

Reported expenses: what this company reported spending on its own lobbying, per quarter, under the accounting method it picked itself.

Before 2025, these bars cover only the lobbying relationships that were still active in 2025 or later. Engagements that ended earlier are not included, so those years may be higher than shown.

Reported income

Q1Q2Q3Q4
$0$250k$500k2016: no report held for Q1, no report held for Q2, $0 Q3, $40k Q420162017: $50k Q1, $50k Q2, $50k Q3, $50k Q420172018: $50k Q1, $50k Q2, $50k Q3, $50k Q420182019: $60k Q1, $60k Q2, $60k Q3, $60k Q420192020: $60k Q1, $60k Q2, $60k Q3, $60k Q420202021: $60k Q1, $68k Q2, $100k Q3, $160k Q420212022: $120k Q1, $113k Q2, $105k Q3, $105k Q420222023: $105k Q1, $105k Q2, $105k Q3, $105k Q420232024: $88k Q1, $88k Q2, $88k Q3, $88k Q420242025: $88k Q1, $76k Q2, $106k Q3, $126k Q420252026: $96k Q1, $86k Q2, $80k Q32026

Reported expenses

Q1Q2Q3Q4
$0$500k$1M2016: no report held for Q1, no report held for Q2, $40k Q3, $80k Q420162017: $140k Q1, $170k Q2, $130k Q3, $130k Q420172018: $240k Q1, $230k Q2, $220k Q3, $110k Q420182019: $280k Q1, $270k Q2, $180k Q3, $170k Q420192020: $360k Q1, $150k Q2, $170k Q3, $150k Q420202021: $235k Q1, $110k Q2, $90k Q3, $100k Q420212022: $210k Q1, $290k Q2, $120k Q3, $190k Q420222023: $180k Q1, $160k Q2, $175k Q3, $105k Q420232024: $170k Q1, $140k Q2, $120k Q3, $100k Q420242025: $160k Q1, $200k Q2, $110k Q3, $260k Q420252026: $200k Q1, $140k Q2, $100k Q32026

Recent activity

Register facts only. Everything on this page comes from filings made under the Lobbying Disclosure Act of 1995 and kept by the Secretary of the Senate. We read the filings, we link a client to a listed company where a reviewed rule allows it, and we add nothing else. No score, no ranking and no judgement is attached to lobbying on this site. See the methodology and about this site.

5 superseded versions left out of the quarterly sums, listed here.

5 of 132 filings
The most recently posted lobbying filings for TVTX
RegistrantFilingAmountPosted RegistrantAmountFilingAll amountsPosted
ALSTON & BIRD LLPfor TRAVERE THERAPEUTICS3rd Quarter - Report3rd Quarter 2026$80,000incomeposted Oct 20, 2026 (LD-2 at lda.gov)Oct 20, 2026 (LD-2 at lda.gov)ALSTON & BIRD LLPfor TRAVERE THERAPEUTICS$80,000income · Oct 203rd Quarter - Report3rd Quarter 2026$80,000incomeOct 20, 2026 (LD-2 at lda.gov)
TRAVERE THERAPEUTICSfor TRAVERE THERAPEUTICS3rd Quarter - Report3rd Quarter 2026$100,000expenses (A)posted Oct 19, 2026 (LD-2 at lda.gov)Oct 19, 2026 (LD-2 at lda.gov)TRAVERE THERAPEUTICSfor TRAVERE THERAPEUTICS$100,000expenses (A) · Oct 193rd Quarter - Report3rd Quarter 2026$100,000expenses (A)Oct 19, 2026 (LD-2 at lda.gov)
THE HEALTH EQUITY STRATEGIES GROUP, LLCfor TRAVERE THERAPEUTICS2nd Quarter - Report2nd Quarter 2026$16,000incomeposted Aug 4, 2026 (LD-2 at lda.gov)Aug 4, 2026 (LD-2 at lda.gov)THE HEALTH EQUITY STRATEGIES GROUP, LLCfor TRAVERE THERAPEUTICS$16,000income · Aug 42nd Quarter - Report2nd Quarter 2026$16,000incomeAug 4, 2026 (LD-2 at lda.gov)
ALSTON & BIRD LLPfor TRAVERE THERAPEUTICS2nd Quarter - Report2nd Quarter 2026$70,000incomeposted Jul 20, 2026 (LD-2 at lda.gov)Jul 20, 2026 (LD-2 at lda.gov)ALSTON & BIRD LLPfor TRAVERE THERAPEUTICS$70,000income · Jul 202nd Quarter - Report2nd Quarter 2026$70,000incomeJul 20, 2026 (LD-2 at lda.gov)
TRAVERE THERAPEUTICSfor TRAVERE THERAPEUTICS2nd Quarter - Report2nd Quarter 2026$140,000expenses (A)posted Jul 20, 2026 (LD-2 at lda.gov)Jul 20, 2026 (LD-2 at lda.gov)TRAVERE THERAPEUTICSfor TRAVERE THERAPEUTICS$140,000expenses (A) · Jul 202nd Quarter - Report2nd Quarter 2026$140,000expenses (A)Jul 20, 2026 (LD-2 at lda.gov)

The link between the client names above and TVTX is a reviewed rule of ours, not something the filing states: an LD-2 names a client and carries no ticker, no CIK and no LEI.